AR and neoplasm: We determined that C‐26 cells and tumor tissue express the androgen receptor (AR; Appendix Fig S3B), but did not detect direct effects of DHT treatment on C‐26 cell viability capable of explaining reduced tumor volumes in the DHT monotherapy group (Appendix Fig S3C).